Text Size
61 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
(HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
2 Recruiting A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
Condition: HIV Infection
Interventions: Biological: HIV-1 Tat/delta-V2 Env combined vaccine;   Biological: HIV-1 delta-V2 Env vaccine;   Biological: HIV-1 Tat vaccine
3 Unknown † Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
4 Recruiting Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-MAG vaccine;   Biological: IL-12 pDNA adjuvant;   Biological: VSV HIV gag vaccine;   Biological: Placebo
5 Recruiting Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women
Condition: HIV Infections
Interventions: Biological: Quadrivalent HPV Vaccine;   Biological: Placebo Vaccine for Male Participants Only;   Biological: Placebo Vaccine for Female Participants Only
6 Recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
7 Not yet recruiting Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine
8 Unknown † Dendritic Cell Vaccine in HIV-1 Infection
Condition: HIV Infections
Intervention: Biological: Dendritic cell vaccine
9 Unknown † Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children
Condition: Acquired Immunodeficiency Syndrome
Intervention: Biological: valent pneumococcal conjugated vaccine
10 Recruiting Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
Condition: HIV Infections
Interventions: Biological: RotaTeq vaccine;   Biological: RotaTeq vaccine placebo
11 Unknown † Project UNITY - HIV Risk Reduction and Vaccine Education Interventions
Conditions: HIV Infections;   Hepatitis B
Intervention: Behavioral: Enhanced HIV risk reduction and HIV vaccine education
12 Not yet recruiting Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
Conditions: Influenza;   Human Immunodeficiency Virus
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
13 Recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
14 Unknown † Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
15 Not yet recruiting Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
16 Unknown † HIV Testing & Womens Attitudes on HIV Vaccine Trials
Condition: HIV Infections
Intervention: Behavioral: Message Sidedness
17 Recruiting Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Condition: HIV Infections
Intervention: Procedure: Blood collection
18 Not yet recruiting Lipopeptide Immunisation With GTU-multiHIV Trial
Condition: HIV-1 Infection
Interventions: Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccines;   Biological: GTU-multHIV B vaccine and LIPO-5 vaccine
19 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
20 Not yet recruiting Immunogenicity and Safety of HPV Vaccine in HIV-infected Pre-adolescent Girls and Boys in Kenya
Conditions: Human Papillomavirus;   HIV-1 Infection
Intervention: Biological: Gardasil vaccine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years